nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—Microtubule Inhibition—Docetaxel—melanoma	0.229	1	CiPCiCtD
Paclitaxel—Docetaxel—melanoma	0.215	1	CrCtD
Paclitaxel—Cabazitaxel—Docetaxel—melanoma	0.123	1	CrCrCtD
Paclitaxel—kidney cancer—melanoma	0.0696	0.509	CtDrD
Paclitaxel—lung cancer—melanoma	0.0671	0.491	CtDrD
Paclitaxel—MAP2—melanoma	0.0535	0.52	CbGaD
Paclitaxel—BCL2—melanoma	0.0261	0.254	CbGaD
Paclitaxel—CYP1B1—melanoma	0.0181	0.176	CbGaD
Paclitaxel—MAP4—Docetaxel—melanoma	0.0177	0.13	CbGbCtD
Paclitaxel—MAPT—Docetaxel—melanoma	0.0128	0.0939	CbGbCtD
Paclitaxel—MAP2—Docetaxel—melanoma	0.0128	0.0939	CbGbCtD
Paclitaxel—BCL2—Docetaxel—melanoma	0.0102	0.0746	CbGbCtD
Paclitaxel—TUBB3—Docetaxel—melanoma	0.00584	0.0428	CbGbCtD
Paclitaxel—TUBB6—Docetaxel—melanoma	0.00584	0.0428	CbGbCtD
Paclitaxel—TUBB8—Docetaxel—melanoma	0.00584	0.0428	CbGbCtD
Paclitaxel—TUBB4A—Docetaxel—melanoma	0.00584	0.0428	CbGbCtD
Paclitaxel—TUBB2B—Docetaxel—melanoma	0.00584	0.0428	CbGbCtD
Paclitaxel—TUBB2A—Docetaxel—melanoma	0.00584	0.0428	CbGbCtD
Paclitaxel—NR1I2—Docetaxel—melanoma	0.00531	0.039	CbGbCtD
Paclitaxel—ABCB1—melanoma	0.00519	0.0505	CbGaD
Paclitaxel—TUBB—Docetaxel—melanoma	0.00488	0.0358	CbGbCtD
Paclitaxel—TUBB4B—Docetaxel—melanoma	0.00488	0.0358	CbGbCtD
Paclitaxel—TUBB1—Docetaxel—melanoma	0.00488	0.0358	CbGbCtD
Paclitaxel—ABCC1—Vemurafenib—melanoma	0.0042	0.0308	CbGbCtD
Paclitaxel—ABCC10—Docetaxel—melanoma	0.00373	0.0274	CbGbCtD
Paclitaxel—ABCG2—Vemurafenib—melanoma	0.00281	0.0206	CbGbCtD
Paclitaxel—ABCC1—Dactinomycin—melanoma	0.00279	0.0205	CbGbCtD
Paclitaxel—SLCO1B3—Docetaxel—melanoma	0.00208	0.0153	CbGbCtD
Paclitaxel—CYP1B1—Docetaxel—melanoma	0.00203	0.0149	CbGbCtD
Paclitaxel—ABCG2—Dactinomycin—melanoma	0.00187	0.0137	CbGbCtD
Paclitaxel—ABCC1—Docetaxel—melanoma	0.00144	0.0106	CbGbCtD
Paclitaxel—CYP3A4—Temozolomide—melanoma	0.00111	0.00813	CbGbCtD
Paclitaxel—ABCC2—Docetaxel—melanoma	0.00107	0.00782	CbGbCtD
Paclitaxel—ABCG2—Docetaxel—melanoma	0.000964	0.00707	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.000712	0.00522	CbGbCtD
Paclitaxel—CYP3A7—Docetaxel—melanoma	0.000712	0.00522	CbGbCtD
Paclitaxel—ABCB1—Dactinomycin—melanoma	0.000673	0.00494	CbGbCtD
Paclitaxel—CYP3A4—Vemurafenib—melanoma	0.000607	0.00445	CbGbCtD
Paclitaxel—CYP3A5—Docetaxel—melanoma	0.000534	0.00392	CbGbCtD
Paclitaxel—MAP4—hair follicle—melanoma	0.000369	0.0548	CbGeAlD
Paclitaxel—ABCB1—Docetaxel—melanoma	0.000348	0.00255	CbGbCtD
Paclitaxel—Docetaxel—MAP2—melanoma	0.000346	0.423	CrCbGaD
Paclitaxel—TUBB4B—skin epidermis—melanoma	0.000246	0.0365	CbGeAlD
Paclitaxel—MAPT—retina—melanoma	0.000232	0.0345	CbGeAlD
Paclitaxel—BCL2—neck—melanoma	0.000225	0.0334	CbGeAlD
Paclitaxel—CYP3A4—Docetaxel—melanoma	0.000208	0.00153	CbGbCtD
Paclitaxel—TUBB—hair follicle—melanoma	0.000206	0.0305	CbGeAlD
Paclitaxel—MAP2—neck—melanoma	0.000195	0.029	CbGeAlD
Paclitaxel—MAP4—eye—melanoma	0.000184	0.0274	CbGeAlD
Paclitaxel—MAP4—retina—melanoma	0.000183	0.0271	CbGeAlD
Paclitaxel—TUBB4B—hair follicle—melanoma	0.000175	0.026	CbGeAlD
Paclitaxel—Docetaxel—BCL2—melanoma	0.000169	0.207	CrCbGaD
Paclitaxel—MAP4—skin of body—melanoma	0.00016	0.0238	CbGeAlD
Paclitaxel—NR1I2—head—melanoma	0.00016	0.0237	CbGeAlD
Paclitaxel—TUBB8—head—melanoma	0.000153	0.0228	CbGeAlD
Paclitaxel—BCL2—skin of body—melanoma	0.000146	0.0216	CbGeAlD
Paclitaxel—MAP2—eye—melanoma	0.000145	0.0216	CbGeAlD
Paclitaxel—MAP2—retina—melanoma	0.000144	0.0214	CbGeAlD
Paclitaxel—CYP1B1—hair follicle—melanoma	0.000139	0.0206	CbGeAlD
Paclitaxel—ABCC1—hair follicle—melanoma	0.000125	0.0185	CbGeAlD
Paclitaxel—Docetaxel—CYP1B1—melanoma	0.000117	0.143	CrCbGaD
Paclitaxel—MAP2—mammalian vulva—melanoma	0.000115	0.0171	CbGeAlD
Paclitaxel—TUBB4A—eye—melanoma	0.000112	0.0167	CbGeAlD
Paclitaxel—TUBB4A—retina—melanoma	0.000111	0.0165	CbGeAlD
Paclitaxel—Docetaxel—EGFR—melanoma	0.000111	0.135	CrCbGaD
Paclitaxel—TUBB2B—eye—melanoma	0.000108	0.0161	CbGeAlD
Paclitaxel—TUBB2B—retina—melanoma	0.000107	0.016	CbGeAlD
Paclitaxel—MAP4—head—melanoma	0.000105	0.0155	CbGeAlD
Paclitaxel—TUBB3—head—melanoma	0.000105	0.0155	CbGeAlD
Paclitaxel—TUBB1—head—melanoma	0.000102	0.0152	CbGeAlD
Paclitaxel—TUBB2A—eye—melanoma	0.000102	0.0152	CbGeAlD
Paclitaxel—TUBB4A—skin of body—melanoma	9.76e-05	0.0145	CbGeAlD
Paclitaxel—BCL2—head—melanoma	9.52e-05	0.0141	CbGeAlD
Paclitaxel—MAPT—lymph node—melanoma	9.32e-05	0.0138	CbGeAlD
Paclitaxel—TUBB2A—skin of body—melanoma	8.88e-05	0.0132	CbGeAlD
Paclitaxel—TUBB6—skin of body—melanoma	8.76e-05	0.013	CbGeAlD
Paclitaxel—TUBB4B—eye—melanoma	8.75e-05	0.013	CbGeAlD
Paclitaxel—TUBB4B—retina—melanoma	8.67e-05	0.0129	CbGeAlD
Paclitaxel—TUBB2B—mammalian vulva—melanoma	8.61e-05	0.0128	CbGeAlD
Paclitaxel—MAP2—head—melanoma	8.24e-05	0.0122	CbGeAlD
Paclitaxel—TUBB—mammalian vulva—melanoma	8.14e-05	0.0121	CbGeAlD
Paclitaxel—TUBB2A—mammalian vulva—melanoma	8.1e-05	0.012	CbGeAlD
Paclitaxel—TUBB6—mammalian vulva—melanoma	7.99e-05	0.0119	CbGeAlD
Paclitaxel—TUBB4B—skin of body—melanoma	7.61e-05	0.0113	CbGeAlD
Paclitaxel—MAP4—lymph node—melanoma	7.33e-05	0.0109	CbGeAlD
Paclitaxel—ABCC10—mammalian vulva—melanoma	7e-05	0.0104	CbGeAlD
Paclitaxel—TUBB4B—mammalian vulva—melanoma	6.94e-05	0.0103	CbGeAlD
Paclitaxel—CYP1B1—eye—melanoma	6.93e-05	0.0103	CbGeAlD
Paclitaxel—BCL2—lymph node—melanoma	6.66e-05	0.00989	CbGeAlD
Paclitaxel—TUBB4A—head—melanoma	6.37e-05	0.00945	CbGeAlD
Paclitaxel—TUBB2B—head—melanoma	6.16e-05	0.00914	CbGeAlD
Paclitaxel—CYP1B1—skin of body—melanoma	6.03e-05	0.00895	CbGeAlD
Paclitaxel—TUBB2A—head—melanoma	5.8e-05	0.0086	CbGeAlD
Paclitaxel—MAP2—lymph node—melanoma	5.77e-05	0.00857	CbGeAlD
Paclitaxel—TUBB6—head—melanoma	5.72e-05	0.00848	CbGeAlD
Paclitaxel—TUBB4B—head—melanoma	4.97e-05	0.00737	CbGeAlD
Paclitaxel—ABCC1—mammalian vulva—melanoma	4.95e-05	0.00734	CbGeAlD
Paclitaxel—ABCB1—blood vessel—melanoma	4.78e-05	0.0071	CbGeAlD
Paclitaxel—TUBB4A—lymph node—melanoma	4.46e-05	0.00662	CbGeAlD
Paclitaxel—TUBB2B—lymph node—melanoma	4.31e-05	0.0064	CbGeAlD
Paclitaxel—CYP19A1—head—melanoma	4.21e-05	0.00625	CbGeAlD
Paclitaxel—Cabazitaxel—ABCB1—melanoma	4.16e-05	0.0509	CrCbGaD
Paclitaxel—ABCG2—mammalian vulva—melanoma	4.1e-05	0.00608	CbGeAlD
Paclitaxel—TUBB—lymph node—melanoma	4.08e-05	0.00605	CbGeAlD
Paclitaxel—TUBB2A—lymph node—melanoma	4.06e-05	0.00602	CbGeAlD
Paclitaxel—TUBB6—lymph node—melanoma	4e-05	0.00594	CbGeAlD
Paclitaxel—CYP1B1—head—melanoma	3.94e-05	0.00584	CbGeAlD
Paclitaxel—ABCC10—lymph node—melanoma	3.5e-05	0.0052	CbGeAlD
Paclitaxel—TUBB4B—lymph node—melanoma	3.48e-05	0.00516	CbGeAlD
Paclitaxel—Docetaxel—ABCB1—melanoma	3.36e-05	0.0411	CrCbGaD
Paclitaxel—CYP19A1—lymph node—melanoma	2.95e-05	0.00438	CbGeAlD
Paclitaxel—ABCC2—lymph node—melanoma	2.81e-05	0.00418	CbGeAlD
Paclitaxel—CYP1B1—lymph node—melanoma	2.76e-05	0.00409	CbGeAlD
Paclitaxel—ABCB1—retina—melanoma	2.52e-05	0.00374	CbGeAlD
Paclitaxel—ABCC1—lymph node—melanoma	2.48e-05	0.00368	CbGeAlD
Paclitaxel—ABCG2—lymph node—melanoma	2.05e-05	0.00305	CbGeAlD
Paclitaxel—ABCB1—mammalian vulva—melanoma	2.02e-05	0.003	CbGeAlD
Paclitaxel—Myalgia—Bleomycin—melanoma	1.84e-05	0.000658	CcSEcCtD
Paclitaxel—Chest pain—Bleomycin—melanoma	1.84e-05	0.000658	CcSEcCtD
Paclitaxel—Abdominal pain upper—Docetaxel—melanoma	1.84e-05	0.000657	CcSEcCtD
Paclitaxel—Orthostatic hypotension—Docetaxel—melanoma	1.84e-05	0.000657	CcSEcCtD
Paclitaxel—Rash—Vemurafenib—melanoma	1.84e-05	0.000656	CcSEcCtD
Paclitaxel—Mental disorder—Temozolomide—melanoma	1.84e-05	0.000656	CcSEcCtD
Paclitaxel—Dermatitis—Vemurafenib—melanoma	1.84e-05	0.000656	CcSEcCtD
Paclitaxel—Back pain—Carmustine—melanoma	1.83e-05	0.000652	CcSEcCtD
Paclitaxel—Headache—Vemurafenib—melanoma	1.83e-05	0.000652	CcSEcCtD
Paclitaxel—Malnutrition—Temozolomide—melanoma	1.83e-05	0.000652	CcSEcCtD
Paclitaxel—Erythema—Temozolomide—melanoma	1.83e-05	0.000652	CcSEcCtD
Paclitaxel—Breast disorder—Docetaxel—melanoma	1.82e-05	0.00065	CcSEcCtD
Paclitaxel—Discomfort—Bleomycin—melanoma	1.82e-05	0.00065	CcSEcCtD
Paclitaxel—Malaise—Dactinomycin—melanoma	1.82e-05	0.00065	CcSEcCtD
Paclitaxel—Toxic epidermal necrolysis—Docetaxel—melanoma	1.82e-05	0.000648	CcSEcCtD
Paclitaxel—Aspartate aminotransferase increased—Docetaxel—melanoma	1.82e-05	0.000648	CcSEcCtD
Paclitaxel—Cramp muscle—Docetaxel—melanoma	1.82e-05	0.000648	CcSEcCtD
Paclitaxel—Leukopenia—Dactinomycin—melanoma	1.81e-05	0.000645	CcSEcCtD
Paclitaxel—Nasopharyngitis—Docetaxel—melanoma	1.8e-05	0.000644	CcSEcCtD
Paclitaxel—Dysgeusia—Temozolomide—melanoma	1.79e-05	0.000638	CcSEcCtD
Paclitaxel—Confusional state—Bleomycin—melanoma	1.78e-05	0.000636	CcSEcCtD
Paclitaxel—Vision blurred—Carmustine—melanoma	1.78e-05	0.000636	CcSEcCtD
Paclitaxel—Alanine aminotransferase increased—Docetaxel—melanoma	1.78e-05	0.000635	CcSEcCtD
Paclitaxel—Tremor—Carmustine—melanoma	1.77e-05	0.000632	CcSEcCtD
Paclitaxel—Anaphylactic shock—Bleomycin—melanoma	1.77e-05	0.000631	CcSEcCtD
Paclitaxel—Oedema—Bleomycin—melanoma	1.77e-05	0.000631	CcSEcCtD
Paclitaxel—Back pain—Temozolomide—melanoma	1.77e-05	0.00063	CcSEcCtD
Paclitaxel—Infection—Bleomycin—melanoma	1.75e-05	0.000626	CcSEcCtD
Paclitaxel—Anaemia—Carmustine—melanoma	1.75e-05	0.000623	CcSEcCtD
Paclitaxel—Dysphagia—Docetaxel—melanoma	1.74e-05	0.000622	CcSEcCtD
Paclitaxel—Agitation—Carmustine—melanoma	1.74e-05	0.00062	CcSEcCtD
Paclitaxel—Nausea—Vemurafenib—melanoma	1.73e-05	0.000618	CcSEcCtD
Paclitaxel—Thrombocytopenia—Bleomycin—melanoma	1.73e-05	0.000617	CcSEcCtD
Paclitaxel—Vision blurred—Temozolomide—melanoma	1.72e-05	0.000614	CcSEcCtD
Paclitaxel—Myalgia—Dactinomycin—melanoma	1.72e-05	0.000613	CcSEcCtD
Paclitaxel—Tremor—Temozolomide—melanoma	1.71e-05	0.000611	CcSEcCtD
Paclitaxel—Discomfort—Dactinomycin—melanoma	1.7e-05	0.000606	CcSEcCtD
Paclitaxel—Ill-defined disorder—Temozolomide—melanoma	1.69e-05	0.000605	CcSEcCtD
Paclitaxel—Leukopenia—Carmustine—melanoma	1.69e-05	0.000604	CcSEcCtD
Paclitaxel—Anaemia—Temozolomide—melanoma	1.69e-05	0.000602	CcSEcCtD
Paclitaxel—Anorexia—Bleomycin—melanoma	1.68e-05	0.000601	CcSEcCtD
Paclitaxel—Agitation—Temozolomide—melanoma	1.68e-05	0.000599	CcSEcCtD
Paclitaxel—Angioedema—Temozolomide—melanoma	1.67e-05	0.000595	CcSEcCtD
Paclitaxel—Pancytopenia—Docetaxel—melanoma	1.65e-05	0.000591	CcSEcCtD
Paclitaxel—Hypotension—Bleomycin—melanoma	1.65e-05	0.000589	CcSEcCtD
Paclitaxel—Oedema—Dactinomycin—melanoma	1.65e-05	0.000588	CcSEcCtD
Paclitaxel—Malaise—Temozolomide—melanoma	1.65e-05	0.000588	CcSEcCtD
Paclitaxel—Vertigo—Temozolomide—melanoma	1.64e-05	0.000586	CcSEcCtD
Paclitaxel—Convulsion—Carmustine—melanoma	1.64e-05	0.000584	CcSEcCtD
Paclitaxel—Infection—Dactinomycin—melanoma	1.64e-05	0.000584	CcSEcCtD
Paclitaxel—Leukopenia—Temozolomide—melanoma	1.63e-05	0.000583	CcSEcCtD
Paclitaxel—Hypertension—Carmustine—melanoma	1.63e-05	0.000582	CcSEcCtD
Paclitaxel—Neutropenia—Docetaxel—melanoma	1.63e-05	0.000582	CcSEcCtD
Paclitaxel—Palpitations—Temozolomide—melanoma	1.61e-05	0.000576	CcSEcCtD
Paclitaxel—Thrombocytopenia—Dactinomycin—melanoma	1.61e-05	0.000576	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Bleomycin—melanoma	1.61e-05	0.000574	CcSEcCtD
Paclitaxel—Chest pain—Carmustine—melanoma	1.61e-05	0.000574	CcSEcCtD
Paclitaxel—Myalgia—Carmustine—melanoma	1.61e-05	0.000574	CcSEcCtD
Paclitaxel—Anxiety—Carmustine—melanoma	1.6e-05	0.000572	CcSEcCtD
Paclitaxel—Cough—Temozolomide—melanoma	1.59e-05	0.000569	CcSEcCtD
Paclitaxel—Paraesthesia—Bleomycin—melanoma	1.59e-05	0.000566	CcSEcCtD
Paclitaxel—Weight increased—Docetaxel—melanoma	1.59e-05	0.000566	CcSEcCtD
Paclitaxel—Convulsion—Temozolomide—melanoma	1.58e-05	0.000565	CcSEcCtD
Paclitaxel—Weight decreased—Docetaxel—melanoma	1.58e-05	0.000563	CcSEcCtD
Paclitaxel—Hypertension—Temozolomide—melanoma	1.58e-05	0.000563	CcSEcCtD
Paclitaxel—Dyspnoea—Bleomycin—melanoma	1.57e-05	0.000562	CcSEcCtD
Paclitaxel—Anorexia—Dactinomycin—melanoma	1.57e-05	0.000561	CcSEcCtD
Paclitaxel—Pneumonia—Docetaxel—melanoma	1.56e-05	0.000558	CcSEcCtD
Paclitaxel—Confusional state—Carmustine—melanoma	1.55e-05	0.000555	CcSEcCtD
Paclitaxel—Myalgia—Temozolomide—melanoma	1.55e-05	0.000555	CcSEcCtD
Paclitaxel—Arthralgia—Temozolomide—melanoma	1.55e-05	0.000555	CcSEcCtD
Paclitaxel—Infestation NOS—Docetaxel—melanoma	1.55e-05	0.000555	CcSEcCtD
Paclitaxel—Infestation—Docetaxel—melanoma	1.55e-05	0.000555	CcSEcCtD
Paclitaxel—Anxiety—Temozolomide—melanoma	1.55e-05	0.000553	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	1.54e-05	0.000551	CcSEcCtD
Paclitaxel—Oedema—Carmustine—melanoma	1.54e-05	0.00055	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Docetaxel—melanoma	1.54e-05	0.00055	CcSEcCtD
Paclitaxel—Discomfort—Temozolomide—melanoma	1.54e-05	0.000548	CcSEcCtD
Paclitaxel—Decreased appetite—Bleomycin—melanoma	1.54e-05	0.000548	CcSEcCtD
Paclitaxel—Infection—Carmustine—melanoma	1.53e-05	0.000547	CcSEcCtD
Paclitaxel—Acute coronary syndrome—Docetaxel—melanoma	1.53e-05	0.000547	CcSEcCtD
Paclitaxel—Renal failure—Docetaxel—melanoma	1.53e-05	0.000545	CcSEcCtD
Paclitaxel—Myocardial infarction—Docetaxel—melanoma	1.52e-05	0.000544	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Docetaxel—melanoma	1.52e-05	0.000544	CcSEcCtD
Paclitaxel—Dry mouth—Temozolomide—melanoma	1.52e-05	0.000543	CcSEcCtD
Paclitaxel—Stomatitis—Docetaxel—melanoma	1.51e-05	0.000541	CcSEcCtD
Paclitaxel—Pain—Bleomycin—melanoma	1.51e-05	0.000539	CcSEcCtD
Paclitaxel—Conjunctivitis—Docetaxel—melanoma	1.51e-05	0.000539	CcSEcCtD
Paclitaxel—Thrombocytopenia—Carmustine—melanoma	1.51e-05	0.000539	CcSEcCtD
Paclitaxel—Tachycardia—Carmustine—melanoma	1.5e-05	0.000537	CcSEcCtD
Paclitaxel—Confusional state—Temozolomide—melanoma	1.5e-05	0.000536	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Dactinomycin—melanoma	1.5e-05	0.000536	CcSEcCtD
Paclitaxel—Anaphylactic shock—Temozolomide—melanoma	1.49e-05	0.000532	CcSEcCtD
Paclitaxel—Oedema—Temozolomide—melanoma	1.49e-05	0.000532	CcSEcCtD
Paclitaxel—Infection—Temozolomide—melanoma	1.48e-05	0.000528	CcSEcCtD
Paclitaxel—Anorexia—Carmustine—melanoma	1.47e-05	0.000525	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Docetaxel—melanoma	1.47e-05	0.000525	CcSEcCtD
Paclitaxel—Epistaxis—Docetaxel—melanoma	1.47e-05	0.000523	CcSEcCtD
Paclitaxel—Nervous system disorder—Temozolomide—melanoma	1.46e-05	0.000522	CcSEcCtD
Paclitaxel—Thrombocytopenia—Temozolomide—melanoma	1.46e-05	0.000521	CcSEcCtD
Paclitaxel—Feeling abnormal—Bleomycin—melanoma	1.46e-05	0.00052	CcSEcCtD
Paclitaxel—Skin disorder—Temozolomide—melanoma	1.45e-05	0.000517	CcSEcCtD
Paclitaxel—ABCB1—head—melanoma	1.45e-05	0.00214	CbGeAlD
Paclitaxel—Hypotension—Carmustine—melanoma	1.44e-05	0.000514	CcSEcCtD
Paclitaxel—Hyperhidrosis—Temozolomide—melanoma	1.44e-05	0.000514	CcSEcCtD
Paclitaxel—Decreased appetite—Dactinomycin—melanoma	1.43e-05	0.000511	CcSEcCtD
Paclitaxel—Fatigue—Dactinomycin—melanoma	1.42e-05	0.000507	CcSEcCtD
Paclitaxel—Anorexia—Temozolomide—melanoma	1.42e-05	0.000507	CcSEcCtD
Paclitaxel—Pain—Dactinomycin—melanoma	1.41e-05	0.000503	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Carmustine—melanoma	1.4e-05	0.000501	CcSEcCtD
Paclitaxel—Urticaria—Bleomycin—melanoma	1.4e-05	0.000501	CcSEcCtD
Paclitaxel—Haemoglobin—Docetaxel—melanoma	1.4e-05	0.0005	CcSEcCtD
Paclitaxel—Rhinitis—Docetaxel—melanoma	1.4e-05	0.000499	CcSEcCtD
Paclitaxel—Body temperature increased—Bleomycin—melanoma	1.4e-05	0.000498	CcSEcCtD
Paclitaxel—Haemorrhage—Docetaxel—melanoma	1.39e-05	0.000498	CcSEcCtD
Paclitaxel—Insomnia—Carmustine—melanoma	1.39e-05	0.000498	CcSEcCtD
Paclitaxel—Hypoaesthesia—Docetaxel—melanoma	1.39e-05	0.000495	CcSEcCtD
Paclitaxel—Paraesthesia—Carmustine—melanoma	1.38e-05	0.000494	CcSEcCtD
Paclitaxel—Pharyngitis—Docetaxel—melanoma	1.38e-05	0.000494	CcSEcCtD
Paclitaxel—Urinary tract disorder—Docetaxel—melanoma	1.38e-05	0.000492	CcSEcCtD
Paclitaxel—Dyspnoea—Carmustine—melanoma	1.37e-05	0.000491	CcSEcCtD
Paclitaxel—Oedema peripheral—Docetaxel—melanoma	1.37e-05	0.00049	CcSEcCtD
Paclitaxel—Somnolence—Carmustine—melanoma	1.37e-05	0.000489	CcSEcCtD
Paclitaxel—Connective tissue disorder—Docetaxel—melanoma	1.37e-05	0.000489	CcSEcCtD
Paclitaxel—Urethral disorder—Docetaxel—melanoma	1.37e-05	0.000488	CcSEcCtD
Paclitaxel—Feeling abnormal—Dactinomycin—melanoma	1.36e-05	0.000485	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Temozolomide—melanoma	1.36e-05	0.000485	CcSEcCtD
Paclitaxel—Insomnia—Temozolomide—melanoma	1.35e-05	0.000481	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Dactinomycin—melanoma	1.35e-05	0.000481	CcSEcCtD
Paclitaxel—Visual impairment—Docetaxel—melanoma	1.34e-05	0.00048	CcSEcCtD
Paclitaxel—Decreased appetite—Carmustine—melanoma	1.34e-05	0.000478	CcSEcCtD
Paclitaxel—Paraesthesia—Temozolomide—melanoma	1.34e-05	0.000478	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Carmustine—melanoma	1.33e-05	0.000475	CcSEcCtD
Paclitaxel—Dyspnoea—Temozolomide—melanoma	1.33e-05	0.000474	CcSEcCtD
Paclitaxel—Somnolence—Temozolomide—melanoma	1.32e-05	0.000473	CcSEcCtD
Paclitaxel—Erythema multiforme—Docetaxel—melanoma	1.32e-05	0.000471	CcSEcCtD
Paclitaxel—Pain—Carmustine—melanoma	1.32e-05	0.000471	CcSEcCtD
Paclitaxel—Constipation—Carmustine—melanoma	1.32e-05	0.000471	CcSEcCtD
Paclitaxel—Dyspepsia—Temozolomide—melanoma	1.31e-05	0.000468	CcSEcCtD
Paclitaxel—Eye disorder—Docetaxel—melanoma	1.3e-05	0.000465	CcSEcCtD
Paclitaxel—Body temperature increased—Dactinomycin—melanoma	1.3e-05	0.000465	CcSEcCtD
Paclitaxel—Abdominal pain—Dactinomycin—melanoma	1.3e-05	0.000465	CcSEcCtD
Paclitaxel—Hypersensitivity—Bleomycin—melanoma	1.3e-05	0.000465	CcSEcCtD
Paclitaxel—Decreased appetite—Temozolomide—melanoma	1.3e-05	0.000462	CcSEcCtD
Paclitaxel—Cardiac disorder—Docetaxel—melanoma	1.29e-05	0.000462	CcSEcCtD
Paclitaxel—Flushing—Docetaxel—melanoma	1.29e-05	0.000462	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Temozolomide—melanoma	1.29e-05	0.000459	CcSEcCtD
Paclitaxel—Fatigue—Temozolomide—melanoma	1.28e-05	0.000459	CcSEcCtD
Paclitaxel—Pain—Temozolomide—melanoma	1.27e-05	0.000455	CcSEcCtD
Paclitaxel—Constipation—Temozolomide—melanoma	1.27e-05	0.000455	CcSEcCtD
Paclitaxel—Feeling abnormal—Carmustine—melanoma	1.27e-05	0.000454	CcSEcCtD
Paclitaxel—Asthenia—Bleomycin—melanoma	1.27e-05	0.000452	CcSEcCtD
Paclitaxel—Angiopathy—Docetaxel—melanoma	1.27e-05	0.000452	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Carmustine—melanoma	1.26e-05	0.00045	CcSEcCtD
Paclitaxel—Immune system disorder—Docetaxel—melanoma	1.26e-05	0.00045	CcSEcCtD
Paclitaxel—Mediastinal disorder—Docetaxel—melanoma	1.26e-05	0.000449	CcSEcCtD
Paclitaxel—Chills—Docetaxel—melanoma	1.25e-05	0.000447	CcSEcCtD
Paclitaxel—Pruritus—Bleomycin—melanoma	1.25e-05	0.000446	CcSEcCtD
Paclitaxel—Arrhythmia—Docetaxel—melanoma	1.25e-05	0.000445	CcSEcCtD
Paclitaxel—Alopecia—Docetaxel—melanoma	1.23e-05	0.00044	CcSEcCtD
Paclitaxel—Feeling abnormal—Temozolomide—melanoma	1.23e-05	0.000438	CcSEcCtD
Paclitaxel—Mental disorder—Docetaxel—melanoma	1.22e-05	0.000436	CcSEcCtD
Paclitaxel—Abdominal pain—Carmustine—melanoma	1.22e-05	0.000435	CcSEcCtD
Paclitaxel—Body temperature increased—Carmustine—melanoma	1.22e-05	0.000435	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Temozolomide—melanoma	1.22e-05	0.000435	CcSEcCtD
Paclitaxel—Erythema—Docetaxel—melanoma	1.21e-05	0.000433	CcSEcCtD
Paclitaxel—Malnutrition—Docetaxel—melanoma	1.21e-05	0.000433	CcSEcCtD
Paclitaxel—Hypersensitivity—Dactinomycin—melanoma	1.21e-05	0.000433	CcSEcCtD
Paclitaxel—Dysgeusia—Docetaxel—melanoma	1.19e-05	0.000424	CcSEcCtD
Paclitaxel—Urticaria—Temozolomide—melanoma	1.18e-05	0.000423	CcSEcCtD
Paclitaxel—Asthenia—Dactinomycin—melanoma	1.18e-05	0.000422	CcSEcCtD
Paclitaxel—Body temperature increased—Temozolomide—melanoma	1.18e-05	0.00042	CcSEcCtD
Paclitaxel—Abdominal pain—Temozolomide—melanoma	1.18e-05	0.00042	CcSEcCtD
Paclitaxel—Back pain—Docetaxel—melanoma	1.17e-05	0.000419	CcSEcCtD
Paclitaxel—Muscle spasms—Docetaxel—melanoma	1.17e-05	0.000417	CcSEcCtD
Paclitaxel—Hypersensitivity—Carmustine—melanoma	1.14e-05	0.000405	CcSEcCtD
Paclitaxel—Diarrhoea—Dactinomycin—melanoma	1.13e-05	0.000402	CcSEcCtD
Paclitaxel—Vomiting—Bleomycin—melanoma	1.12e-05	0.000401	CcSEcCtD
Paclitaxel—Anaemia—Docetaxel—melanoma	1.12e-05	0.000401	CcSEcCtD
Paclitaxel—Rash—Bleomycin—melanoma	1.11e-05	0.000398	CcSEcCtD
Paclitaxel—Dermatitis—Bleomycin—melanoma	1.11e-05	0.000397	CcSEcCtD
Paclitaxel—Asthenia—Carmustine—melanoma	1.11e-05	0.000395	CcSEcCtD
Paclitaxel—Hypersensitivity—Temozolomide—melanoma	1.1e-05	0.000392	CcSEcCtD
Paclitaxel—Syncope—Docetaxel—melanoma	1.09e-05	0.000389	CcSEcCtD
Paclitaxel—Leukopenia—Docetaxel—melanoma	1.09e-05	0.000388	CcSEcCtD
Paclitaxel—Palpitations—Docetaxel—melanoma	1.07e-05	0.000383	CcSEcCtD
Paclitaxel—Asthenia—Temozolomide—melanoma	1.07e-05	0.000382	CcSEcCtD
Paclitaxel—Loss of consciousness—Docetaxel—melanoma	1.07e-05	0.000381	CcSEcCtD
Paclitaxel—Cough—Docetaxel—melanoma	1.06e-05	0.000378	CcSEcCtD
Paclitaxel—Diarrhoea—Carmustine—melanoma	1.06e-05	0.000377	CcSEcCtD
Paclitaxel—Pruritus—Temozolomide—melanoma	1.05e-05	0.000376	CcSEcCtD
Paclitaxel—Convulsion—Docetaxel—melanoma	1.05e-05	0.000376	CcSEcCtD
Paclitaxel—Nausea—Bleomycin—melanoma	1.05e-05	0.000375	CcSEcCtD
Paclitaxel—Hypertension—Docetaxel—melanoma	1.05e-05	0.000374	CcSEcCtD
Paclitaxel—Vomiting—Dactinomycin—melanoma	1.05e-05	0.000374	CcSEcCtD
Paclitaxel—Rash—Dactinomycin—melanoma	1.04e-05	0.000371	CcSEcCtD
Paclitaxel—Chest pain—Docetaxel—melanoma	1.03e-05	0.000369	CcSEcCtD
Paclitaxel—Myalgia—Docetaxel—melanoma	1.03e-05	0.000369	CcSEcCtD
Paclitaxel—Arthralgia—Docetaxel—melanoma	1.03e-05	0.000369	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	1.03e-05	0.000366	CcSEcCtD
Paclitaxel—Dizziness—Carmustine—melanoma	1.02e-05	0.000364	CcSEcCtD
Paclitaxel—Diarrhoea—Temozolomide—melanoma	1.02e-05	0.000364	CcSEcCtD
Paclitaxel—ABCB1—lymph node—melanoma	1.01e-05	0.0015	CbGeAlD
Paclitaxel—Dry mouth—Docetaxel—melanoma	1.01e-05	0.000361	CcSEcCtD
Paclitaxel—Confusional state—Docetaxel—melanoma	9.99e-06	0.000357	CcSEcCtD
Paclitaxel—Anaphylactic shock—Docetaxel—melanoma	9.91e-06	0.000354	CcSEcCtD
Paclitaxel—Oedema—Docetaxel—melanoma	9.91e-06	0.000354	CcSEcCtD
Paclitaxel—Dizziness—Temozolomide—melanoma	9.85e-06	0.000352	CcSEcCtD
Paclitaxel—Infection—Docetaxel—melanoma	9.84e-06	0.000351	CcSEcCtD
Paclitaxel—Vomiting—Carmustine—melanoma	9.8e-06	0.00035	CcSEcCtD
Paclitaxel—Nausea—Dactinomycin—melanoma	9.79e-06	0.000349	CcSEcCtD
Paclitaxel—Shock—Docetaxel—melanoma	9.75e-06	0.000348	CcSEcCtD
Paclitaxel—Rash—Carmustine—melanoma	9.72e-06	0.000347	CcSEcCtD
Paclitaxel—Nervous system disorder—Docetaxel—melanoma	9.72e-06	0.000347	CcSEcCtD
Paclitaxel—Dermatitis—Carmustine—melanoma	9.71e-06	0.000347	CcSEcCtD
Paclitaxel—Thrombocytopenia—Docetaxel—melanoma	9.7e-06	0.000346	CcSEcCtD
Paclitaxel—Tachycardia—Docetaxel—melanoma	9.67e-06	0.000345	CcSEcCtD
Paclitaxel—Headache—Carmustine—melanoma	9.66e-06	0.000345	CcSEcCtD
Paclitaxel—Skin disorder—Docetaxel—melanoma	9.63e-06	0.000344	CcSEcCtD
Paclitaxel—Vomiting—Temozolomide—melanoma	9.47e-06	0.000338	CcSEcCtD
Paclitaxel—Anorexia—Docetaxel—melanoma	9.45e-06	0.000337	CcSEcCtD
Paclitaxel—Rash—Temozolomide—melanoma	9.4e-06	0.000335	CcSEcCtD
Paclitaxel—Dermatitis—Temozolomide—melanoma	9.39e-06	0.000335	CcSEcCtD
Paclitaxel—Headache—Temozolomide—melanoma	9.34e-06	0.000333	CcSEcCtD
Paclitaxel—Hypotension—Docetaxel—melanoma	9.26e-06	0.000331	CcSEcCtD
Paclitaxel—Nausea—Carmustine—melanoma	9.16e-06	0.000327	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Docetaxel—melanoma	9.03e-06	0.000322	CcSEcCtD
Paclitaxel—Insomnia—Docetaxel—melanoma	8.96e-06	0.00032	CcSEcCtD
Paclitaxel—Paraesthesia—Docetaxel—melanoma	8.9e-06	0.000318	CcSEcCtD
Paclitaxel—Nausea—Temozolomide—melanoma	8.85e-06	0.000316	CcSEcCtD
Paclitaxel—Dyspnoea—Docetaxel—melanoma	8.83e-06	0.000315	CcSEcCtD
Paclitaxel—Somnolence—Docetaxel—melanoma	8.81e-06	0.000314	CcSEcCtD
Paclitaxel—Dyspepsia—Docetaxel—melanoma	8.72e-06	0.000311	CcSEcCtD
Paclitaxel—Decreased appetite—Docetaxel—melanoma	8.61e-06	0.000307	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Docetaxel—melanoma	8.56e-06	0.000305	CcSEcCtD
Paclitaxel—Fatigue—Docetaxel—melanoma	8.54e-06	0.000305	CcSEcCtD
Paclitaxel—Pain—Docetaxel—melanoma	8.47e-06	0.000302	CcSEcCtD
Paclitaxel—Constipation—Docetaxel—melanoma	8.47e-06	0.000302	CcSEcCtD
Paclitaxel—Feeling abnormal—Docetaxel—melanoma	8.17e-06	0.000291	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Docetaxel—melanoma	8.1e-06	0.000289	CcSEcCtD
Paclitaxel—Abdominal pain—Docetaxel—melanoma	7.83e-06	0.00028	CcSEcCtD
Paclitaxel—Body temperature increased—Docetaxel—melanoma	7.83e-06	0.00028	CcSEcCtD
Paclitaxel—Hypersensitivity—Docetaxel—melanoma	7.3e-06	0.000261	CcSEcCtD
Paclitaxel—Asthenia—Docetaxel—melanoma	7.11e-06	0.000254	CcSEcCtD
Paclitaxel—Pruritus—Docetaxel—melanoma	7.01e-06	0.00025	CcSEcCtD
Paclitaxel—Diarrhoea—Docetaxel—melanoma	6.78e-06	0.000242	CcSEcCtD
Paclitaxel—Dizziness—Docetaxel—melanoma	6.55e-06	0.000234	CcSEcCtD
Paclitaxel—Vomiting—Docetaxel—melanoma	6.3e-06	0.000225	CcSEcCtD
Paclitaxel—Rash—Docetaxel—melanoma	6.25e-06	0.000223	CcSEcCtD
Paclitaxel—Dermatitis—Docetaxel—melanoma	6.24e-06	0.000223	CcSEcCtD
Paclitaxel—Headache—Docetaxel—melanoma	6.21e-06	0.000222	CcSEcCtD
Paclitaxel—Nausea—Docetaxel—melanoma	5.89e-06	0.00021	CcSEcCtD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	6.55e-07	3.04e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—VCAN—melanoma	6.52e-07	3.02e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PPARG—melanoma	6.47e-07	3e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PRKCA—melanoma	6.45e-07	2.99e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PRKCA—melanoma	6.43e-07	2.98e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ERCC2—melanoma	6.4e-07	2.97e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ERCC2—melanoma	6.37e-07	2.95e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP17A1—melanoma	6.35e-07	2.94e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PLA2G6—melanoma	6.32e-07	2.93e-05	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—AKT1—melanoma	6.26e-07	2.9e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CD—melanoma	6.26e-07	2.9e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PLCB4—melanoma	6.24e-07	2.89e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PRKCA—melanoma	6.22e-07	2.88e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NOS2—melanoma	6.21e-07	2.88e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—ALB—melanoma	6.18e-07	2.86e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	6.17e-07	2.86e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ERCC2—melanoma	6.16e-07	2.86e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NOTCH1—melanoma	6.15e-07	2.85e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—STAT3—melanoma	6.15e-07	2.85e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ABCB1—melanoma	6.14e-07	2.85e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—NRAS—melanoma	6.13e-07	2.84e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ABCB1—melanoma	6.09e-07	2.82e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CD80—melanoma	6.02e-07	2.79e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	6.01e-07	2.79e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KIT—melanoma	6.01e-07	2.79e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—APC—melanoma	6.01e-07	2.79e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GNA11—melanoma	6e-07	2.78e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.96e-07	2.76e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EGF—melanoma	5.94e-07	2.75e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PLA2G6—melanoma	5.91e-07	2.74e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CD—melanoma	5.89e-07	2.73e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—MAPK3—melanoma	5.87e-07	2.72e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIP4K2A—melanoma	5.87e-07	2.72e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SLC6A11—melanoma	5.87e-07	2.72e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—FASN—melanoma	5.87e-07	2.72e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	5.82e-07	2.7e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—ALB—melanoma	5.81e-07	2.7e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—SLC5A5—melanoma	5.77e-07	2.68e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—MTAP—melanoma	5.71e-07	2.65e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—VCAN—melanoma	5.68e-07	2.63e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PRKCA—melanoma	5.65e-07	2.62e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—BRAF—melanoma	5.65e-07	2.62e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ERCC2—melanoma	5.61e-07	2.6e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PRKCA—melanoma	5.6e-07	2.6e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—MAPK1—melanoma	5.59e-07	2.59e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—EGFR—melanoma	5.59e-07	2.59e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CD44—melanoma	5.58e-07	2.59e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GNAQ—melanoma	5.58e-07	2.59e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ERCC2—melanoma	5.56e-07	2.58e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP17A1—melanoma	5.5e-07	2.55e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CB—melanoma	5.46e-07	2.53e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.43e-07	2.52e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTGS2—melanoma	5.41e-07	2.51e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	5.36e-07	2.48e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP1B1—melanoma	5.35e-07	2.48e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MAP2K1—melanoma	5.32e-07	2.47e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—VCAN—melanoma	5.31e-07	2.46e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.3e-07	2.46e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CD—melanoma	5.28e-07	2.45e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.28e-07	2.45e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—KRAS—melanoma	5.28e-07	2.45e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GNA11—melanoma	5.19e-07	2.41e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CB—melanoma	5.13e-07	2.38e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.11e-07	2.37e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PHGDH—melanoma	5.09e-07	2.36e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—LUM—melanoma	5.09e-07	2.36e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTGS2—melanoma	5.09e-07	2.36e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—FASN—melanoma	5.08e-07	2.36e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—FGF2—melanoma	5.06e-07	2.35e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CG—melanoma	5.06e-07	2.34e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CG—melanoma	5.03e-07	2.33e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.02e-07	2.33e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SLC5A5—melanoma	5e-07	2.32e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HPSE—melanoma	4.99e-07	2.31e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	4.91e-07	2.28e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CUBN—melanoma	4.9e-07	2.27e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PPARG—melanoma	4.88e-07	2.26e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CG—melanoma	4.87e-07	2.26e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PPARG—melanoma	4.86e-07	2.25e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.85e-07	2.25e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PIK3CA—melanoma	4.85e-07	2.25e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GNAQ—melanoma	4.83e-07	2.24e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CD44—melanoma	4.83e-07	2.24e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP17A1—melanoma	4.79e-07	2.22e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MDM2—melanoma	4.73e-07	2.19e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SDHD—melanoma	4.73e-07	2.19e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CSPG4—melanoma	4.73e-07	2.19e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—BSG—melanoma	4.73e-07	2.19e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.73e-07	2.19e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTEN—melanoma	4.71e-07	2.19e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PPARG—melanoma	4.7e-07	2.18e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.69e-07	2.17e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—ERBB2—melanoma	4.67e-07	2.16e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP1B1—melanoma	4.63e-07	2.15e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CB—melanoma	4.61e-07	2.14e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CD4—melanoma	4.6e-07	2.13e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GPAM—melanoma	4.58e-07	2.12e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTGS2—melanoma	4.56e-07	2.12e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GNA11—melanoma	4.53e-07	2.1e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HRAS—melanoma	4.49e-07	2.08e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP17A1—melanoma	4.48e-07	2.08e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CD—melanoma	4.44e-07	2.06e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	4.44e-07	2.06e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTEN—melanoma	4.44e-07	2.06e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CG—melanoma	4.43e-07	2.05e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—FASN—melanoma	4.43e-07	2.05e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CD—melanoma	4.42e-07	2.05e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.42e-07	2.05e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ABCB1—melanoma	4.4e-07	2.04e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CG—melanoma	4.39e-07	2.04e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ALB—melanoma	4.39e-07	2.03e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ALB—melanoma	4.37e-07	2.03e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	4.36e-07	2.02e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SLC5A5—melanoma	4.36e-07	2.02e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CDKN1B—melanoma	4.32e-07	2e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL6—melanoma	4.29e-07	1.99e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CD—melanoma	4.28e-07	1.98e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PPARG—melanoma	4.27e-07	1.98e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PPARG—melanoma	4.24e-07	1.96e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GNA11—melanoma	4.23e-07	1.96e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ALB—melanoma	4.22e-07	1.96e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CD44—melanoma	4.21e-07	1.95e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GNAQ—melanoma	4.21e-07	1.95e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—FASN—melanoma	4.14e-07	1.92e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.09e-07	1.89e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CTNNB1—melanoma	4.08e-07	1.89e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SLC5A5—melanoma	4.07e-07	1.89e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PRKCA—melanoma	4.05e-07	1.88e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP1B1—melanoma	4.03e-07	1.87e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ERCC2—melanoma	4.02e-07	1.86e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CDKN1A—melanoma	3.99e-07	1.85e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTEN—melanoma	3.98e-07	1.85e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—AKT1—melanoma	3.96e-07	1.84e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CD44—melanoma	3.93e-07	1.82e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GNAQ—melanoma	3.93e-07	1.82e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PLA2G6—melanoma	3.9e-07	1.81e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CD—melanoma	3.89e-07	1.81e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CB—melanoma	3.87e-07	1.8e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CD—melanoma	3.86e-07	1.79e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CB—melanoma	3.86e-07	1.79e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.85e-07	1.78e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ALB—melanoma	3.84e-07	1.78e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTGS2—melanoma	3.84e-07	1.78e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTGS2—melanoma	3.82e-07	1.77e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.81e-07	1.77e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ABCB1—melanoma	3.81e-07	1.77e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ALB—melanoma	3.81e-07	1.77e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP1B1—melanoma	3.77e-07	1.75e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CB—melanoma	3.73e-07	1.73e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTGS2—melanoma	3.7e-07	1.71e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—STAT3—melanoma	3.56e-07	1.65e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NRAS—melanoma	3.55e-07	1.65e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PRKCA—melanoma	3.51e-07	1.63e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—VCAN—melanoma	3.5e-07	1.62e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ERCC2—melanoma	3.48e-07	1.61e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MAPK3—melanoma	3.4e-07	1.58e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CB—melanoma	3.39e-07	1.57e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CB—melanoma	3.36e-07	1.56e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTGS2—melanoma	3.36e-07	1.56e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTEN—melanoma	3.35e-07	1.55e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTGS2—melanoma	3.33e-07	1.55e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTEN—melanoma	3.33e-07	1.55e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.33e-07	1.54e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CA—melanoma	3.33e-07	1.54e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MYC—melanoma	3.31e-07	1.53e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MAPK1—melanoma	3.24e-07	1.5e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EGFR—melanoma	3.23e-07	1.5e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTEN—melanoma	3.22e-07	1.49e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CG—melanoma	3.17e-07	1.47e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CA—melanoma	3.13e-07	1.45e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ABCB1—melanoma	3.1e-07	1.44e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PPARG—melanoma	3.06e-07	1.42e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PRKCA—melanoma	3.06e-07	1.42e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KRAS—melanoma	3.06e-07	1.42e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ERCC2—melanoma	3.03e-07	1.41e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP17A1—melanoma	2.95e-07	1.37e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTEN—melanoma	2.93e-07	1.36e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTEN—melanoma	2.91e-07	1.35e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.88e-07	1.34e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PRKCA—melanoma	2.86e-07	1.32e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ERCC2—melanoma	2.83e-07	1.31e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CA—melanoma	2.81e-07	1.3e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CD—melanoma	2.79e-07	1.29e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GNA11—melanoma	2.79e-07	1.29e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ALB—melanoma	2.75e-07	1.28e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CG—melanoma	2.75e-07	1.27e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—FASN—melanoma	2.73e-07	1.27e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—AKT1—melanoma	2.72e-07	1.26e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SLC5A5—melanoma	2.68e-07	1.24e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PPARG—melanoma	2.65e-07	1.23e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HRAS—melanoma	2.6e-07	1.2e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GNAQ—melanoma	2.59e-07	1.2e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CD44—melanoma	2.59e-07	1.2e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—AKT1—melanoma	2.56e-07	1.19e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IL6—melanoma	2.49e-07	1.15e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP1B1—melanoma	2.49e-07	1.15e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CB—melanoma	2.43e-07	1.13e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CD—melanoma	2.42e-07	1.12e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTGS2—melanoma	2.41e-07	1.12e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CG—melanoma	2.39e-07	1.11e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ALB—melanoma	2.39e-07	1.11e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CA—melanoma	2.36e-07	1.09e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CA—melanoma	2.35e-07	1.09e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.35e-07	1.09e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PPARG—melanoma	2.31e-07	1.07e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—AKT1—melanoma	2.29e-07	1.06e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CA—melanoma	2.27e-07	1.05e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CG—melanoma	2.24e-07	1.04e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PPARG—melanoma	2.16e-07	1e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CB—melanoma	2.11e-07	9.77e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CD—melanoma	2.11e-07	9.76e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTEN—melanoma	2.1e-07	9.74e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTGS2—melanoma	2.09e-07	9.68e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ALB—melanoma	2.08e-07	9.64e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CA—melanoma	2.07e-07	9.59e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CA—melanoma	2.05e-07	9.51e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ABCB1—melanoma	2.05e-07	9.49e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CD—melanoma	1.97e-07	9.12e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ALB—melanoma	1.94e-07	9e-06	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AKT1—melanoma	1.93e-07	8.94e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AKT1—melanoma	1.92e-07	8.91e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PRKCA—melanoma	1.88e-07	8.73e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ERCC2—melanoma	1.87e-07	8.66e-06	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AKT1—melanoma	1.86e-07	8.61e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CB—melanoma	1.83e-07	8.51e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTEN—melanoma	1.82e-07	8.44e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTGS2—melanoma	1.82e-07	8.43e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CB—melanoma	1.71e-07	7.95e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTGS2—melanoma	1.7e-07	7.87e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AKT1—melanoma	1.69e-07	7.84e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AKT1—melanoma	1.68e-07	7.77e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTEN—melanoma	1.59e-07	7.35e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CA—melanoma	1.48e-07	6.87e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTEN—melanoma	1.48e-07	6.87e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CG—melanoma	1.48e-07	6.84e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PPARG—melanoma	1.42e-07	6.6e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CD—melanoma	1.3e-07	6.01e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CA—melanoma	1.28e-07	5.95e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALB—melanoma	1.28e-07	5.94e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AKT1—melanoma	1.21e-07	5.61e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CB—melanoma	1.13e-07	5.24e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTGS2—melanoma	1.12e-07	5.19e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CA—melanoma	1.12e-07	5.19e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AKT1—melanoma	1.05e-07	4.86e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CA—melanoma	1.04e-07	4.84e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTEN—melanoma	9.77e-08	4.53e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AKT1—melanoma	9.14e-08	4.24e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AKT1—melanoma	8.54e-08	3.96e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CA—melanoma	6.89e-08	3.2e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKT1—melanoma	5.63e-08	2.61e-06	CbGpPWpGaD
